• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TEOXANE RHA2 RESILIENT HYALURONIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TEOXANE RHA2 RESILIENT HYALURONIC ACID Back to Search Results
Catalog Number 940007
Device Problem Off-Label Use (1494)
Patient Problems Erythema (1840); Hypersensitivity/Allergic reaction (1907); Itching Sensation (1943); Injection Site Reaction (4562)
Event Date 02/07/2021
Event Type  Injury  
Event Description
Allergic symptoms [hypersensitivity]. Firm lumps in lips and chin [injection site mass]. Rha2 injected into top and bottom lip [off label use]. United states report received from a patient on 08-feb-2021. A female patient of unknown age received rha 2 on (b)(6) 2021; dose and frequency were unknown. An unknown volume was applied to the lips and chin using an unknown injection technique and 30-gauge needle supplied from the box. It was not reported whether a cannula was used for administration of rha 2. Previous cosmetic procedures included dermal fillers including juvederm, radiesse kysse, and belotero. Medical history included puffiness following injection of belotero, allergy to penicillin, as well as a previously positive covid-19 diagnosis on an unknown date in (b)(6) 2020. The patient did not receive the covid-19 vaccine. Concomitant medications and food supplements were not provided. On (b)(6) 2021 at 3:00 am, 10 days following the injection of rha 2, the patient experienced an allergic reaction. At 5:00 am, the patient's tongue became swollen. The patient's allergic reaction was further clarified as a swollen lips, face, and jaws. On (b)(6) 2021, the patient then took an unknown amount of benedryl and visited the emergency room, in which she was treated with additional doses of benadryl, prednisone, and iv pepcid. The patient noted there were no gastrointestinal symptoms present. The patient left the emergency room the same day. The patient noted that she had gotten a foster dog the night before on (b)(6) 2021, and has since returned the dog, but stated that her allergic symptoms have persisted. The patient further clarified that the allergic reaction was localized in her face, and that on (b)(6) 2021, 11 days following the injection of rha 2, she stated her chin had become red, lumpy and itchy. On (b)(6) 2021, the patient was injected with hylanex/hyaluronidase to dissolve the filler, but it is unknown in which locations the hyaluronidase was injected. Following the injection of hylanex, the patient still had a couple of firm lumps in her lips (one on the top lip and a couple on the bottom lip). The patient continues to treat with benadryl, although she clarified she is taking less benadryl at the time of this report (5:00 pm on (b)(6) 2021). She stated she has two more dose of prednisone to take. The outcome of the events of allergic reaction was resolving. The outcome of the events of itchy chin and firm lumps on lips was unknown. The intensity of the events was not provided. It was unknown if the product was available for return. (b)(4). No additional information was available at the time of the report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameRHA2
Type of DeviceRESILIENT HYALURONIC ACID
Manufacturer (Section D)
TEOXANE
les charmilles
rue de lyon, 105
geneva, CH-12 03
SZ CH-1203
MDR Report Key11402066
MDR Text Key234412577
Report Number3007772056-2021-00002
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial
Report Date 02/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/02/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Catalogue Number940007
Device Lot Number202414B0
Was Device Available for Evaluation? No Answer Provided
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date02/08/2021
Event Location No Information
Was Device Evaluated by Manufacturer? No Answer Provided
Is the Device Single Use? No Answer Provided
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage

Patient Treatment Data
Date Received: 03/02/2021 Patient Sequence Number: 1
-
-